Phathom Pharmaceuticals (PHAT) Current Leases (2019 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Current Leases came in at $667000.0 in Q1 2026, up 111.08% year-on-year from $316000.0 in Q1 2025, and up 2.93% on a QoQ basis from $648000.0 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Current Leases (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 8 years of Current Leases data on file, last reported at $667000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 111.08% year-over-year to $667000.0 in Q1 2026; TTM through Mar 2026 was $667000.0, a 111.08% increase from a year earlier, with the FY2025 full-year figure at $648000.0, up 29.34% from the prior year.
- Current Leases for Q1 2026 stood at $667000.0, up from $648000.0 in the prior quarter.
- Over the last five years, Current Leases for PHAT reached as high as $730000.0 in Q1 2024 and fell as low as $238000.0 in Q2 2025.
- Historically, Current Leases has averaged $616352.9 across 5 years, with a median of $680000.0 in 2024.
- Across the five-year window, Current Leases plunged 66.94% in 2025 and soared 111.08% in 2026, its largest moves.
- Year by year, Current Leases stood at $708000.0 in 2022, then increased by 2.54% to $726000.0 in 2023, then tumbled by 30.99% to $501000.0 in 2024, then grew by 29.34% to $648000.0 in 2025, then grew by 2.93% to $667000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $667000.0 in Q1 2026, $648000.0 in Q4 2025, and $591000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn | 667,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 648,000.00 |
| Sep 30, 2025 | 591,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 316,000.00 |
| Dec 31, 2024 | 501,000.00 |
| Sep 30, 2024 | 680,000.00 |
| Jun 30, 2024 | 720,000.00 |
| Mar 31, 2024 | 730,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Sep 30, 2023 | 721,000.00 |
| Jun 30, 2023 | 717,000.00 |
| Mar 31, 2023 | 712,000.00 |
| Dec 31, 2022 | 708,000.00 |
| Sep 30, 2022 | 685,000.00 |
| Jun 30, 2022 | 628,000.00 |
| Mar 31, 2022 | 490,000.00 |
| Dec 31, 2021 | 487,000.00 |
| Sep 30, 2021 | 484,000.00 |
| Jun 30, 2021 | 480,000.00 |